Institutional investors hold a majority ownership of AMGN through the 83.49% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2014, these large investors purchased a net $11.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE SECURITIES (USA) L... Bought 3.3 Million shares of Amgen
UBS SECURITIES LLC Bought 3.0 Million shares of Amgen
JANA PARTNERS LLC Bought 2.8 Million shares of Amgen